Oriel Therapeutics

Talecris Biotherapeutics Inc is a biopharmaceutical company based in Durham, NC. Specializing in the development and production of plasma-derived therapies, the company focuses on improving the lives of patients with rare and chronic diseases. Generated from their business information

BioCryst Pharmaceuticals designs, optimizes and develops novel small-molecule drugs that treat cancer, cardiovascular and autoimmune diseases and viral infections. BioCryst uses structure-based drug design, which incorporates multiple scientific disciplines, including biology, crystallography, medicinal chemistry and computer modeling. In structure-based drug design, scientists use detailed knowledge of the active sites of protein targets associated with particular diseases to design synthetic compounds that fight the disease. Structure-based drug design aims to create a molecule that will bind to the active site of a targeted enzyme, thereby preventing the normal chemical reaction and ultimately halting the progression of the disease. BioCryst was founded in 1986. The Company's stock is traded on the NASDAQ exchange under the symbol BCRX.

Integrated Laboratory Systems provides comprehensive research, testing and support services in the health and environmental science markets. Its scientists and technicians have experience and expertise in a wide range of health and environmental disciplines, including environmental sciences, clinical research, investigative toxicology, molecular and pathological research, and alternative methods and bio-information. Most recently, ILS has moved into the clinical research arena with the award of a major contract studying Anencephaly. ILS' research facilities are located in Research Triangle Park, N.C.; Athens, Ga.; Golden, Colo.; and Washington, D.C. Integrated Laboratory Systems was founded as a research laboratory in 1985 by Dr. Thomas K. Rao.